Top Markets
#1 Islamic Coin Islamic Coin +155.97%
#2 Siren Siren +37.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.25%
#4 Verus Coin Verus Coin +22.40%
#5 Cysic Cysic +19.84%
#6 Arowana Arowana +19.40%
#7 OpenEden OpenEden +17.23%
#8 Perle Perle +14.78%
#9 Ocean Protocol Ocean Protocol +13.13%
#10 RedStone RedStone +12.61%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rang in aandelen #31791
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Aandeelprijs
$0.21291741
Laatst gesynchroniseerd: 2025-04-18
Marktkapitalisatie
$12.07M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
KR
Handel PCL, Inc. (241820)

Categorie

Healthcare
P/S-ratio voor PCL, Inc. (241820)
P/S-ratio op August 2026 TTM: 3.15
Volgens de meest recente financiële rapporten en aandelenkoers van PCL, Inc. is de huidige P/S-ratio (TTM) 3.15. Eind 2023 had het bedrijf een P/S-ratio van 18.24.
P/S-ratiohistoriek voor PCL, Inc. van 2015 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
2026 (TTM) 3.15 -87.36%
2024 24.96 36.88%
2023 18.24 283.15%
2022 4.76 -45.57%
2021 8.74 19.24%
2020 7.33 -99.68%
2019 2.28K 207.15%
2018 742.49 119.01%
2017 339.03 117.88%
2016 155.60 -58.72%
2015 376.97 0.00%
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 30.99%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 59.53%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -11.73%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 16.30%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 156.71%
US